ALKBH7 activators form a niche class of chemicals that are of significant interest within the biochemical research community for their role in modulating cellular processes. As enzymes that belong to the AlkB family of dioxygenases, ALKBH7's typical involvement lies in the metabolic regulation within mitochondria and the controlled induction of apoptosis under certain cellular conditions. The activators of ALKBH7 are characterized by their ability to upregulate the expression of this protein, often through epigenetic mechanisms. These compounds typically function by altering the chromatin state around the ALKBH7 gene, making it more accessible for transcription machinery. This modulation is primarily achieved through the inhibition of histone deacetylases (HDACs), leading to an increase in histone acetylation and a consequent loosening of chromatin structure. As a result, the transcription factors have better access to DNA, enhancing the expression of ALKBH7. While these chemicals do not directly interact with the ALKBH7 gene or protein, their influence on the epigenetic landscape is a pivotal factor in the upregulation process.
The diversity within the class of ALKBH7 activators is reflective of the various steps and components involved in gene expression pathways. Some activators may affect the transcriptional level by modulating the activity of transcription factors or coactivators associated with the ALKBH7 gene. Others might exert their effects post-transcriptionally, by influencing mRNA stability or translation efficiency. The study of ALKBH7 activators is intricate, as the upregulation of ALKBH7 is a multifaceted process that can be impacted by a range of cellular contexts, including nutrient availability and cellular stress responses. Consequently, these activators are valuable tools for probing the biological functions of ALKBH7, particularly in understanding how cells regulate metabolic pathways in response to internal and external stimuli. By elucidating the pathways through which ALKBH7 is upregulated, researchers can gain insights into the broader regulatory networks that maintain cellular homeostasis and respond to metabolic demands.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
May increase ALKBH7 transcription by promoting histone acetylation and an open chromatin configuration at the ALKBH7 gene locus. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Could upregulate ALKBH7 by inhibiting HDAC activity, thereby allowing transcription factors access to the ALKBH7 promoter. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Might enhance ALKBH7 expression through inhibition of HDACs, leading to a more transcriptionally permissive state. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
May selectively increase ALKBH7 transcription by altering histone acetylation patterns specifically at the ALKBH7 gene. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
Could potentially lead to ALKBH7 upregulation by broadly increasing histone acetylation and affecting gene transcription networks. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $153.00 $561.00 | ||
Might upregulate ALKBH7 expression by changing acetylation levels of histones associated with the ALKBH7 gene. | ||||||